BIODESIX INC (BDSX) [Rocket]

In millions, except per share items	Dec-31-22	Dec-05-22	Dec-31-21	Dec-05-21	Dec-31-20	Dec-31-19	Dec-31-18
	10-K	8-K	10-K	8-K	10-K	10-K	S-1/A
Revenues:
Diagnostic Tests					40.9	17.3
Services					4.6	7.2
Total revenues	38.2	13.1	54.5	12.8	45.6	24.6
Revenue growth [+]	-29.9%	2.4%	19.6%		85.6%
Diagnostic Tests					136.3%
Services					-35.9%
Cost of goods sold	0.0	-25.1	0.0	-41.7	0.0	0.0
Gross profit	38.2	38.2	54.5	54.5	45.6	24.6
Gross margin	100.0%	291.7%	100.0%	426.2%	100.0%	100.0%
Selling, general and administrative	88.8	61.5	95.4	50.5	34.9	30.6
Research and development					10.8	10.5
Other operating expenses	15.1	27.3	2.2	44.9	22.0	6.1
EBITDA [+]	-62.0		-40.0		-19.2	-19.8
EBITDA growth	55.1%	23.6%	108.1%		-3.1%
EBITDA margin	-162.4%	-386.1%	-73.4%	-320.1%	-42.2%	-80.8%
Depreciation	1.6		1.2		0.8	0.8
EBITA	-63.7	-50.6	-41.2	-40.9	-20.1	-20.7
EBITA margin	-166.6%	-386.1%	-75.6%	-320.1%	-44.0%	-84.1%
Amortization of intangibles	2.0		2.0		2.1	2.0
EBIT [+]	-65.6	-50.6	-43.2	-40.9	-22.1	-22.6
EBIT growth	52.1%	23.6%	95.2%		-2.3%
EBIT margin	-171.8%	-386.1%	-79.2%	-320.1%	-48.5%	-92.2%
Non-recurring items [+]					0.8	4.1
Unusual expense					0.8	4.1
Interest expense, net [+]		8.1		4.5	7.6	3.0
Interest expense	8.1	8.1	4.5	4.5	7.6	3.0
Interest income					0.0	0.1
Other income (expense), net [+]	8.3	-6.8	4.5	2.3	-0.8	-1.0
Change in fair value of warrants	-0.1				-1.3	-0.1
Other non-operating income	0.1		0.0		0.4	1.1
Other	0.1	-0.1	0.0	0.0	-8.4	-4.0
Pre-tax income	-65.4	-65.4	-43.2	-43.2	-31.4	-30.7
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-65.4	-65.4	-43.2	-43.2	-31.4	-30.7
Net margin	-171.3%	-499.5%	-79.2%	-337.5%	-68.8%	-125.1%

Basic EPS [+]	($1.55)	($1.55)	($1.58)	($1.58)	($6.48)	($126.97)
Growth	-1.4%	-1.4%	-75.7%		-94.9%
Diluted EPS [+]	($1.55)	($1.55)	($1.58)	($1.58)	($6.48)	($126.97)
Growth	-1.4%	-1.4%	-75.7%		-94.9%

Shares outstanding (basic) [+]	42.1	42.1	27.4	27.4	4.8	0.2
Growth	53.9%	53.9%	465.6%		1899.2%
Shares outstanding (diluted) [+]	42.1	42.1	27.4	27.4	4.8	0.2
Growth	53.9%	53.9%	465.6%		1899.2%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.